脑转移患者急诊就诊后转院模式与预测因素分析
该研究基于2018至2019年马萨诸塞州医疗成本与利用项目数据库,分析3037例急诊就诊的脑转移患者,发现6.9%被转院,转出急诊多为无神经外科和放射肿瘤服务的非教学医院,转院患者更常伴神经系统症状,约30%转院后未接受重大操作。
要点
- 急诊就诊的脑转移患者中6.9%转院,转出医院多为无神经外科和放射肿瘤服务的非教学医院(p < 0.01)。
- 转院患者较收治或离院患者更常以神经系统症状就诊(p < 0.01)。
- 74%的转院患者被送往距离大于3英里的更远机构,但远距离转院与30天再入院率、90天再入院率及住院时长无显著差异。
核心结论
- 相当比例的转院患者转院后未接受重大操作或可观的医疗管理,可能反映急诊医师对脑转移神经系统症状的不安。
- 许多患者被转至距出发地较远的医院,但再入院率和住院时长无差异。
研究设计与样本
- 分析2018年和2019年马萨诸塞州医疗成本与利用项目州住院患者数据库和州急诊部数据库中3037例急诊就诊的脑转移患者。
主要发现
- 6.9%的急诊就诊脑转移患者直接或入院后间接转至其他机构。
- 转出急诊更可能为无神经外科和放射肿瘤服务的非教学医院(p < 0.01)。
- 转院患者较收治或离院患者更常以神经系统症状就诊(p < 0.01)。
- 转院患者中约30%转院后未接受重大操作,约10%在3天内离院且未接受重大干预。
- 74%的转院患者被送往距离大于3英里的更远机构,而非最近的具备神经外科和放射肿瘤服务的机构。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Interhospital transfers in the acute setting may contribute to high cost, patient inconvenience, and delayed treatment. The authors sought to understand patterns and predictors in the transfer of brain metastasis patients after emergency department (ED) encounter. METHODS: The authors analyzed 3037 patients with brain metastasis who presented to the ED in Massachusetts and were included in the Healthcare Cost and Utilization Project State Inpatient Database and State Emergency Department Database in 2018 and 2019. RESULTS: The authors found that 6.9% of brain metastasis patients who presented to the ED were transferred to another facility, either directly or indirectly after admission. The sending EDs were more likely to be nonteaching hospitals without neurosurgery and radiation oncology services (p < 0.01). Transferred patients were more likely to present with neurological symptoms compared to those admitted or discharged (p < 0.01). Among those transferred, approximately 30% did not undergo a significant procedure after transfer and approximately 10% were discharged within 3 days, in addition to not undergoing significant interventions. In total, 74% of transferred patients were sent to a facility significantly farther (> 3 miles) than the nearest facility with neurosurgery and radiation oncology services. Further distance transfers were not associated with improvements in 30-day readmission rate (OR [95% CI] 0.64 [0.30-1.34] for 15-30 miles; OR [95% CI] 0.73 [0.37-1.46] for > 30 miles), 90-day readmission rate (OR [95% CI] 0.50 [0.18-1.28] for 15-30 miles; OR [95% CI] 0.53 [0.18-1.51] for > 30 miles), and length of stay (OR [95% CI] 1.21 days [0.94-1.29] for both 15-30 miles and > 30 miles) compared to close-distance transfers. CONCLUSIONS: The authors identified a notable proportion of transfers without subsequent significant intervention or appreciable medical management. This may reflect ED physician discomfort with the neurological symptoms of brain metastasis. Many patients were also transferred to hospitals distant from their point of origin and demonstrated no differences in readmission rates and length of stay.
引用
- Tong L, Medeiros L, Moen EL, et al. Dissecting patterns and predictors of interhospital transfers for patients with brain metastasis. J Neurosurg. 2023. PMID: 37486906. doi:10.3171/2023.5.JNS222922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。